Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 4/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.37 |
| ▸ | ACE | P12821 | 3/20 | 0.37 |
| ▸ | REN | P00797 | 2/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.36 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29396694 | 1.00 | CAPN1 (0.41) | CAPN1OPRM1OPRD1ACEREN | |
| SCHEMBL30139043 | 0.97 | REN (0.39) | OPRM1OPRD1ACEREN | |
| SCHEMBL30211634 | 0.94 | CAPN1 (0.43) | CAPN1OPRM1OPRD1ACEREN | |
| SCHEMBL29376028 | 0.94 | OPRM1 (0.43) | CAPN1OPRM1OPRD1RENCTSB | |
| SCHEMBL29375930 | 0.94 | OPRM1 (0.43) | CAPN1OPRM1OPRD1RENCTSB | |
| SCHEMBL31259075 | 0.93 | CAPN1 (0.44) | CAPN1OPRM1OPRD1CTSBBDKRB2 | |
| SCHEMBL29757422 | 0.91 | CAPN1 (0.51) | CAPN1OPRM1OPRD1CTSB | |
| SCHEMBL31140016 | 0.91 | CAPN1 (0.41) | CAPN1OPRM1OPRD1RENBDKRB2 | |
| SCHEMBL30013216 | 0.91 | CAPN1 (0.41) | CAPN1OPRM1OPRD1RENBDKRB2 | |
| SCHEMBL677175 | 0.91 | CAPN1 (0.39) | CAPN1OPRM1OPRD1RENCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264785-A1 | CHEMICALLY MODIFIED PEPTIDES AND USE THEREOF | NEUROCRINE BIOSCIENCES, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| CN-115521368-B | Exendin-4 derivatives | 江苏鸿永医药技术有限公司 | 2024-08-23 | — | — | CN | disclosed |